Treatment of Lipoxin A4 and its analogue on low-dose endotoxin induced preeclampsia in rat and possible mechanisms

Reproductive Toxicology

Volumn 34, Issue 4, 2012, Pages 677-685

  Lin, Feng ^a   Zeng, Pan ^b   Xu, Zhangye ^a   Ye, Duyun ^b   Yu, Xiaofang ^a   Wang, Ni ^a   Tang, Jie ^a   Zhou, Ye ^a   Huang, Yinping ^a  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; Inflammation; Lipoxin; Preeclampsia; Trophoblast

Indexed keywords

7 TRIHYDROXYMETHYL HEPTANOIC ACID; ALBUMIN; BML 111; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LIPOXIN A; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FETUS WEIGHT; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HYPERTENSION; NONHUMAN; PLACENTA PERFUSION; PLACENTA WEIGHT; PREECLAMPSIA; PROTEIN EXPRESSION; PROTEINURIA; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYMPTOMATOLOGY; SYSTOLIC BLOOD PRESSURE; TROPHOBLAST; UPREGULATION; WEIGHT GAIN;

ALBUMINURIA; ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; BLOOD PRESSURE; CELL LINE; CELL PROLIFERATION; CYTOKINES; FEMALE; HEPTANOIC ACIDS; HUMANS; LIPOPOLYSACCHARIDES; LIPOXINS; PRE-ECLAMPSIA; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

RATTUS; TOBACCO ETCH VIRUS;

EID: 84868259229     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2012.09.009     Document Type: Article

References (51)

1. Young B.C., Levine R.J., Karumanchi S.A. Pathogenesis of preeclampsia. Annual Review of Pathology 2010, 5:173-192.
2. Whitley G.S., Dash P.R., Ayling L.J., Prefumo F., Thilaganathan B., Cartwright J.E. Increased apoptosis in first trimester extravillous trophoblasts from pregnancies at higher risk of developing preeclampsia. American Journal of Pathology 2007, 170:1903-1909.
3. Sargent I.L., Germain S.J., Sacks G.P., Kumar S., Redman C.W. Trophoblast deportation and the maternal inflammatory response in pre-eclampsia. Journal of Reproductive Immunology 2003, 59(2):153-160.
4. Serhan C.N., Savill J. Resolution of inflammation: the beginning programs the end. Nature Immunology 2005, 6(12):1191-1197.
5. Maderna P., Godson C. Lipoxins: resolutionary road. British Journal of Pharmacology 2009, 158(4):947-959.
6. Liu S., Wu P., Ye D., Huang Y., Zhou X., Li Y., et al. Effects of lipoxin A(4) on CoCl(2)-induced angiogenesis and its possible mechanisms in human umbilical vein endothelial cells. Pharmacology 2009, 84(1):17-23.
7. 4 on lipopolysaccharide-induced endothelial hyperpermeability. TheScientificWorldJournal 2011, 11:1056-1067.
8. Gilbert J.S., Ryan M.J., LaMarca B.B., Sedeek M., Murphy S.R., Granger J.P. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. American Journal of Physiology. Heart and Circulatory Physiology 2008, 294(2):H541-H550.
9. Liao W.X., Laurent L., Agent S., Hodges J., Chen D.B. Human placental expression of slit/robo signaling cues: effects of preeclampsia and hypoxia. Biology of Reproduction 2012, 86(4):111.
10. Sun Y.P., Tjonahen E., Keledjian R., Zhu M., Yang R., Recchiuti A., et al. Anti-inflammatory and pro-resolving properties of benzo-lipoxin A(4) analogs. Prostaglandins Leukotrienes and Essential Fatty Acids 2009, 81(5-6):357-366.
11. Lee T.H., Lympany P., Crea A.E., Spur B.W. Inhibition of leukotriene B4-induced neutrophil migration by lipoxin A4: structure-function relationships. Biochemical and Biophysical Research Communications 1991, 180(3):1416-1421.
12. Zhang L., Wan J., Li H., Wu P., Jin S., Zhou X., et al. Protective effects of BML-111, a lipoxin A(4) receptor agonist, on carbon tetrachloride-induced liver injury in mice. Hepatology Research 2007, 37(11):948-956.
13. 2+ current ICRAC. Archives of Biochemistry and Biophysics 2008, 478(1):110-118.
14. 4 and its analogue suppress the tumor growth of transplanted H22 in mice: the role of antiangiogenesis. Molecular Cancer Therapeutics 2010, 9(8):2164-2174.
15. Faas M.M., Schuiling G.A., Baller J.F., Visscher C.A., Bakker W.W. A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats. American Journal of Obstetrics and Gynecology 1994, 171(1):158-164.
16. Anderson C.M., Lopez F., Zimmer A., Benoit J.N. Placental insufficiency leads to developmental hypertension and mesenteric artery dysfunction in two generations of Sprague-Dawley rat offspring. Biology of Reproduction 2006, 74(3):538-544.
17. Feng H.C., Choy M.Y., Deng W., Wong H.L., Lau W.M., Cheung A.N., et al. Establishment and characterization of a human first-trimester extravillous trophoblast cell line (TEV-1). Journal of the Society for Gynecologic Investigation 2005, 12(4):e21-e32.
18. Bonnans C., Gras D., Chavis C., Mainprice B., Vachier I., Godard P., et al. Synthesis and anti-inflammatory effect of lipoxins in human airway epithelial cells. Biomedicine & Pharmacotherapy 2007, 61(5):261-267.
19. Mayhew T.M., Leach L., McGee R., Ismail W.W., Myklebust R., Lammiman M.J. Proliferation, differentiation and apoptosis in villous trophoblast at 13-41 weeks of gestation (including observations on annulate lamellae and nuclear pore complexes). Placenta 1999, 20(5-6):407-422.
20. Vitoratos N., Economou E., Iavazzo C., Panoulis K., Creatsas G. Maternal serum levels of TNF-alpha and IL-6 long after delivery in preeclamptic and normotensive pregnant women. Mediators of Inflammation 2010, 2010. 908649.
21. Arikan D.C., Aral M., Coskun A., Ozer A. Plasma IL-4, IL-8, IL-12, interferon-gamma and CRP levels in pregnant women with preeclampsia, and their relation with severity of disease and fetal birth weight. Journal of Maternal-Fetal and Neonatal Medicine 2012, 30. [Epub ahead of print].
22. Tosun M., Celik H., Avci B., Yavuz E., Alper T., Malatyalioglu E. Maternal and umbilical serum levels of interleukin-6, interleukin-8, and tumor necrosis factor-alpha in normal pregnancies and in pregnancies complicated by preeclampsia. Journal of Maternal-Fetal and Neonatal Medicine 2010, 23(8):880-886.
23. Levy R. The role of apoptosis in preeclampsia. Israel Medical Association Journal 2005, 7(3):178-181.
24. Maru Y. Encounter of cancer cells with bone. Cancer and inflammation - input and output of NF-κB-Clinical Calcium 2011, 21(3):364-371.
25. Faas M.M., Schuiling G.A., Linton E.A., Sargent I.L., Redman C.W. Activation of peripheral leukocytes in rat pregnancy and experimental preeclampsia. American Journal of Obstetrics and Gynecology 2000, 182(2):351-357.
26. Faas M.M., Schuiling G.A., Baller J.F., Valkhof N., Bakker W.W. Aspirin treatment of the low-dose-endotoxin-treated pregnant rat: pathophysiologic and immunohistologic aspects. Journal of Laboratory and Clinical Medicine 1997, 130(5):496-508.
27. Sakawi Y., Tarpey M., Chen Y.F., Calhoun D.A., Connor M.G., Chestnut D.H., et al. Evaluation of low-dose endotoxin administration during pregnancy as a model of preeclampsia. Anesthesiology 2000, 93(6):1446-1455.
28. Rinehart B.K., Terrone D.A., Lagoo-Deenadayalan S., Barber W.H., Hale E.A., Martin J.N., et al. Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1beta, and interleukin 10 is increased in preeclampsia. American Journal of Obstetrics and Gynecology 1999, 181(4):915-920.
29. Conrad K.P., Benyo D.F. Placental cytokines and the pathogenesis of preeclampsia. American Journal of Reproductive Immunology 1997, 37(3):240-249.
30. Velzing-Aarts F.V., Muskiet F.A., van der Dijs F.P., Duits A.J. High serum interleukin-8 levels in afro-Caribbean women with pre-eclampsia. Relations with tumor necrosis factor-alpha, duffy negative phenotype and von willebrand factor. American Journal of Reproductive Immunology 2002, 48(5):319-322.
31. Rivera D.L., Olister S.M., Liu X., Thompson J.H., Zhang X.J., Pennline K., et al. Interleukin-10 attenuates experimental fetal growth restriction and demise. FASEB Journal 1998, 12(2):189-197.
32. Ruano R., Fontes R.S., Zugaib M. Prevention of preeclampsia with low-dose aspirin - a systematic review and meta-analysis of the main randomized controlled trials. Clinics (Sao Paulo) 2005, 60(5):407-414.
33. Trivedi N.A. A meta-analysis of low-dose aspirin for prevention of preeclampsia. Journal of Postgraduate Medicine 2011, 57(2):91-95.
34. Golding J. A randomised trial of low dose aspirin for primiparae in pregnancy. The Jamaica Low Dose Aspirin Study Group. British Journal of Obstetrics and Gynaecology 1998, 105(3):293-299.
35. Caritis S., Sibai B., Hauth J., Lindheimer M.D., Klebanoff M., Thom E., et al. Low-dose aspirin to prevent preeclampsia in women at high risk, National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. New England Journal of Medicine 1998, 338(11):701-705.
36. Ostensen M.E., Skomsvoll J.F. Anti-inflammatory pharmacotherapy during pregnancy. Expert Opinion on Pharmacotherapy 2004, 5(9):571-580.
37. Spite M., Serhan C.N. Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins. Circulation Research 2010, 107:1170-1184.
38. Faber B.M., Metz S.A., Chegini N. Immunolocalization of eicosanoid enzymes and growth factors in human myometrium and fetoplacental tissues in failed labor inductions. Obstetrics and Gynecology 1996, 88(2):174-179.
39. Alexander B.T., Bennett W.A., Khalil R.A., Granger J.P. Preeclampsia: linking placental ischemia with cardiovascular-renal dysfunction. News in Physiological Sciences 2001, 16:282-286.
40. Brown N.L., Slater D.M., Alvi S.A., Elder M.G., Sullivan M.H., Bennett P.R. Expression of 5-lipoxygenase and 5-lipoxygenase-activating protein in human fetal membranes throughout pregnancy and at term. Molecular Human Reproduction 1999, 5(7):668-674.
41. Viatour P., Merville M.P., Bours V., Chariot A. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends in Biochemical Sciences 2005, 30(1):43-52.
42. Luppi P., Tse H., Lain K.Y., Markovic N., Piganelli J.D., DeLoia J.A. Preeclampsia activates circulating immune cells with engagement of the NF-kappaB pathway. American Journal of Reproductive Immunology 2006, 56(2):135-144.
43. Chiang N., Serhan C.N., Dahlén S.E., Drazen J.M., Hay D.W., Rovati G.E., et al. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacological Reviews 2006, 58(3):463-487.
44. Leung D.N., Smith S.C., To K.F., Sahota D.S., Baker P.N. Increased placental apoptosis in pregnancies complicated by preeclampsia. American Journal of Obstetrics and Gynecology 2001, 184(6):1249-1250.
45. Allaire A.D., Ballenger K.A., Wells S.R., McMahon M.J., Lessey B.A. Placental apoptosis in preeclampsia. Obstetrics and Gynecology 2000, 96(2):271-276.
46. Ishihara N., Matsuo H., Murakoshi H., Laoag-Fernandez J.B., Samoto T., Maruo T. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. American Journal of Obstetrics and Gynecology 2002, 186(1):158-166.
47. 4. Pediatric Research 2008, 64(4):393-398.
48. Simoes R.L., Niconi-de-Almeida Y., da-Fe A.R., Barja-Fidalgo C., Fierro I.M. A synthetic analog of 15-epi-lipoxin A4 inhibits human monocyte apoptosis: involvement of ERK-2 and PI3-kinase. Prostaglandins & Other Lipid Mediators 2010, 91(1-2):10-17.
49. Prieto P., Cuenca J., Traves P.G., Fernandez-Velasco M., Martin-Sanz P., Bosca L. Lipoxin A4 impairment of apoptotic signaling in macrophages: implication of the PI3k/Akt and the ERK/Nrf-2 defense pathways. Cell Death and Differentiation 2010, 17(7):1179-1188.
50. Sakuragi N., Matsuo H., Coukos G., Furth E.E., Bronner M.P., VanArsdale C.M., et al. Differentiation-dependent expression of the Bcl-2 proto-oncogene in the human trophoblast lineage. Journal of the Society for Gynecologic Investigation 1994, 1(2):164-172.
51. Kim C.J., Choe Y.J., Yoon B.H., Kim C.W., Chi J.G. Patterns of Bcl-2 expression in placenta. Pathology, Research and Practice 1995, 191(12):1239-1244.